Overview
Translational research
Diagnostics, therapies and cures
Stem cells
Studying pluripotent stem cells will help us understand more about the early stages of embryonic development
Understanding human diseases
To develop new therapies and cures
Using embryonic development
To understand human health and disease
Understanding muscle development and disease
Will lead to new therapies for muscular dystrophies
Translational research
Developing therapies for type 2 diabetes
Defining the molecular and cellular basis of human disease
Will define new approaches to treat neurological and cardiovascular disease
The Center for Molecular Medicine’s mission is to better understand the molecular and cellular basis of human disease and to use this information to guide the development of new diagnostics, therapies, and cures.
Research areas include:
- Use of stem cells in cardiovascular, neurological and metabolic disease
- Human disease modeling with human induced pluripotent stem cells (iPSCs)
- Drug discovery
- Tissue engineering
- Vaccine development
Congratulations to Dr. Jinglian Tao who has been awarded a 2024 American Heart Association Postdoctoral Fellowship.
Dr. Tao is part of Dr. Natalia Ivanova’s lab group at the CMM.
Learn more about Dr. Tao’s work here.
On November 17th, 2022, The Zeltner Lab published their open-access article “Norepinephrine transporter defects lead to sympathetic hyperactivity in Familial Dysautonomia models”in the journal Nature Communications. Use the link above to see the full article.
Zeltner Lab
Efficient Differentiation of Postganglionic Sympathetic Neurons using Human Pluripotent Stem Cells under Feeder-free and Chemically Defined Culture Conditions
